Insider Trading Alert - APO, CFX And Y Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 15, 2014, 142 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $600.00 to $30,330,507.50.

Highlighted Stocks Traded by Insiders:

Apollo Global Management (APO) - FREE Research Report

Ducey Michael E, who is Director at Apollo Global Management, bought 1,500 shares at $25.59 on May 15, 2014. Following this transaction, the Director owned 750 shares meaning that the stake was reduced by 200% with the 1,500-share transaction.

The shares most recently traded at $24.60, down $0.99, or 4.02% since the insider transaction. Historical insider transactions for Apollo Global Management go as follows:

  • 4-Week # shares bought: 2,211
  • 4-Week # shares sold: 12,100
  • 12-Week # shares bought: 3,711
  • 12-Week # shares sold: 12,100
  • 24-Week # shares bought: 3,711
  • 24-Week # shares sold: 107,919

The average volume for Apollo Global Management has been 1.2 million shares per day over the past 30 days. Apollo Global Management has a market cap of $3.8 billion and is part of the financial sector and financial services industry. Shares are down 20.03% year-to-date as of the close of trading on Thursday.

Apollo Global Management, LLC is a publicly owned investment manager. It primarily provides its services to endowment and sovereign wealth funds, as well as other institutional and individual investors. The firm manages client focused portfolios. The stock currently has a dividend yield of 16.54%. The company has a P/E ratio of 9.3. Currently, there are 8 analysts who rate Apollo Global Management a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on APO - FREE

TheStreet Quant Ratings rates Apollo Global Management as a hold. Among the primary strengths of the company is its expanding profit margins over time. At the same time, however, we also find weaknesses including unimpressive growth in net income, a generally disappointing performance in the stock itself and feeble growth in the company's earnings per share. Get the full Apollo Global Management Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Colfax (CFX) - FREE Research Report

Kiefaber Clay, who is ESAB Global CEO & EVP - Colfax at Colfax, sold 10,800 shares at $71.58 on May 15, 2014. Following this transaction, the ESAB Global CEO & EVP - Colfax owned 113,889 shares meaning that the stake was reduced by 8.66% with the 10,800-share transaction.

The shares most recently traded at $71.67, up $0.09, or 0.13% since the insider transaction. Historical insider transactions for Colfax go as follows:

  • 4-Week # shares sold: 7,200
  • 12-Week # shares sold: 7,200
  • 24-Week # shares sold: 7,200

The average volume for Colfax has been 669,400 shares per day over the past 30 days. Colfax has a market cap of $9.1 billion and is part of the industrial goods sector and industrial industry. Shares are up 13.28% year-to-date as of the close of trading on Thursday.

Colfax Corporation, a diversified industrial manufacturing and engineering company, provides gas-and fluid-handling and fabrication technology products and services to commercial and governmental customers worldwide. The company has a P/E ratio of 47.5. Currently, there are 2 analysts who rate Colfax a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CFX - FREE

TheStreet Quant Ratings rates Colfax as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, growth in earnings per share and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Colfax Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Alleghany (Y) - FREE Research Report

Lavin William K, who is Director at Alleghany, sold 250 shares at $414.57 on May 15, 2014. Following this transaction, the Director owned 2,313 shares meaning that the stake was reduced by 9.75% with the 250-share transaction.

The shares most recently traded at $408.13, down $6.44, or 1.58% since the insider transaction. Historical insider transactions for Alleghany go as follows:

  • 12-Week # shares sold: 1,650
  • 24-Week # shares bought: 300
  • 24-Week # shares sold: 1,650

The average volume for Alleghany has been 67,000 shares per day over the past 30 days. Alleghany has a market cap of $6.8 billion and is part of the financial sector and insurance industry. Shares are up 1.97% year-to-date as of the close of trading on Thursday.

Alleghany Corporation, together with its subsidiaries, provides various insurance services in the United States. The company operates in two segments, Reinsurance and Insurance. The company has a P/E ratio of 10.9. Currently, there are no analysts who rate Alleghany a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on Y - FREE

TheStreet Quant Ratings rates Alleghany as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, increase in stock price during the past year and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Alleghany Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug